OraSure Technologies, Inc.

NASDAQ:OSUR

Medical - Instruments & Supplies

Healthcare
$3.59 -3.47%

-$0.16 today

Market cap
$247.88M
Beta
1.01
P/E (TTM)
-4.0
EPS (TTM)
-$1.08
52W Low $2.08High $4.58

Volume 0.49M

Average 0.61M

OSUR Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

OraSure Technologies, Inc.NASDAQ: OSUR

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares declines year over year

Q1 FY2026 weighted avg shares of 69.68M shares fell 6.9% year over year, behind the -3.1% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 2.6% from the prior quarter. Over 3 fiscal years it compounded at +0.4% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -6.9% toward the trailing-twelve-month pace of -3.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
69.68M-2.6% QoQ
Last fiscal yearDec 2025
73.49M-1.3% YoY
LTMMar 2026
72.2M-3.1% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.9%——
1 year-1.3%——
3-year CAGR+0.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
73.49M USD
Year-over-year change
-1.3%
4-year CAGR
+0.5%

Weighted Avg Shares vs competitors

How OSUR compares with its peers on the latest reported figures

  • OSUR's LTM Mar 2026 weighted avg shares of 72.2M shares is the 2nd highest of the 10 companies compared; the peer median is 39.55M shares.
  • Its year-over-year change of -3.1% is the 7th highest of 9, against a peer median of +16.1%.
  • Over three fiscal years its annual growth of +0.4% compares with a peer median of +13.5%.
OSUR Competitors Peer median
Weighted Avg Shares for OSUR and competitors
Company Period LTM YoY 3-year CAGR
NAUTNautilus Biotechnology, Inc.LTM Mar 2026126.35M +0.5%+0.4%
OSUROraSure Technologies, Inc.LTM Mar 202672.2M -3.1%+0.4%
STIMNeuronetics, Inc.LTM Mar 202667.96M +71.5%+34.8%
CATXPerspective Therapeutics, Inc.LTM Mar 202654.95M -21.6%+10.4%
TARAProtara Therapeutics, Inc.LTM Mar 202643.36M +56.7%+56.1%
NYXHNyxoah S.A.LTM Mar 202639.55M +13.3%+13.9%
PROFProfound Medical Corp.LTM Mar 202631.8M +21.2%+13.2%
NTHINeonc Technologies Holdings, Inc.LTM Mar 202620.19M ——
PREPrenetics Global LimitedLTM Mar 202615.04M +18.8%+40.5%
UTMDUtah Medical Products, Inc.LTM Mar 20263.28M -4.9%-3.1%
Peer median (excluding OSUR) 39.55M+16.1%+13.5%

Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue233.67M387.48M405.47M185.83M115.02M
Cost of Revenue116.07M239.04M226.05M109.6M66.82M
Gross Profit117.6M148.44M179.42M76.23M48.2M
Gross Margin50.3%38.3%44.2%41.0%41.9%
Research & Development34.17M36.24M33.16M24.42M42.53M
Selling, General & Admin95.08M117.44M92.18M72.41M73.79M
Operating Expenses129.25M153.68M125.34M96.83M116.32M
Depreciation & Amortization11.66M14M19.9M10.87M9.97M
EBITDA2.37M(1.68M)76.16M(6.83M)(56.96M)
EBITDA Margin1.0%-0.4%18.8%-3.7%-49.5%
Operating Income(11.65M)(5.24M)54.08M(20.6M)(68.12M)
Operating Margin-5.0%-1.4%13.3%-11.1%-59.2%
Interest Income00000
Interest Expense00000
Other Income / Expenses2.36M(10.43M)2.18M2.9M1.19M
Income Before Tax(9.29M)(15.68M)56.26M(17.7M)(66.93M)
Pre-Tax Margin-4.0%-4.0%13.9%-9.5%-58.2%
Income Tax Expense13.71M1.46M2.6M1.8M1.8M
Net Income(23M)(17.13M)53.66M(19.5M)(68.73M)
Net Margin-9.8%-4.4%13.2%-10.5%-59.8%
EPS (Basic)(0.32)(0.25)0.73(0.26)(0.94)
EPS (Diluted)(0.32)(0.25)0.72(0.26)(0.94)
Weighted Avg Shares71.98M72.51M73.35M74.43M73.49M
Weighted Avg Shares (Diluted)71.98M72.51M74.39M74.43M73.49M

OraSure Technologies, Inc.

NASDAQ:OSUR

Intrinsic Alpha fair value

Locked

Current Price

$3.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.